Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma ; volume:14 ; number:1 ; day:11 ; month:3 ; year:2014 ; pages:1-7 ; date:12.2014
BMC urology ; 14, Heft 1 (11.3.2014), 1-7, 12.2014
- Creator
-
Tsuchiya, Norihiko
- Contributor
-
Yuasa, Takeshi
Maita, Shinya
Narita, Shintaro
Inoue, Takamitsu
Numakura, Kazuyuki
Saito, Mitsuru
Satoh, Shigeru
Yonese, Junji
Habuchi, Tomonori
SpringerLink (Online service)
- DOI
-
10.1186/1471-2490-14-26
- URN
-
urn:nbn:de:1111-2016071626159
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsuchiya, Norihiko
- Yuasa, Takeshi
- Maita, Shinya
- Narita, Shintaro
- Inoue, Takamitsu
- Numakura, Kazuyuki
- Saito, Mitsuru
- Satoh, Shigeru
- Yonese, Junji
- Habuchi, Tomonori
- SpringerLink (Online service)
Other Objects (12)
Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A
PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1
Snail heterogeneity in clear cell renal cell carcinoma
FOXD1 regulates cell division in clear cell renal cell carcinoma
MCPIP1 contributes to clear cell renal cell carcinomas development
RARE DISTINCT SUBTYPE OF CLEAR CELL RENAL CELL CARCINOMA - MULTILOCULAR CYSTIC RENAL CELL CARCINOMA
CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway
Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma
Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A
PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1
Snail heterogeneity in clear cell renal cell carcinoma
FOXD1 regulates cell division in clear cell renal cell carcinoma
MCPIP1 contributes to clear cell renal cell carcinomas development
RARE DISTINCT SUBTYPE OF CLEAR CELL RENAL CELL CARCINOMA - MULTILOCULAR CYSTIC RENAL CELL CARCINOMA
CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway
Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma
Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A
PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1
Snail heterogeneity in clear cell renal cell carcinoma
FOXD1 regulates cell division in clear cell renal cell carcinoma
MCPIP1 contributes to clear cell renal cell carcinomas development
RARE DISTINCT SUBTYPE OF CLEAR CELL RENAL CELL CARCINOMA - MULTILOCULAR CYSTIC RENAL CELL CARCINOMA
CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway